AR124640A1 - Cicatrización de heridas - Google Patents

Cicatrización de heridas

Info

Publication number
AR124640A1
AR124640A1 ARP210103231A ARP210103231A AR124640A1 AR 124640 A1 AR124640 A1 AR 124640A1 AR P210103231 A ARP210103231 A AR P210103231A AR P210103231 A ARP210103231 A AR P210103231A AR 124640 A1 AR124640 A1 AR 124640A1
Authority
AR
Argentina
Prior art keywords
patient
patients
fibrinogenase
ulcers
effective amount
Prior art date
Application number
ARP210103231A
Other languages
English (en)
Inventor
Valery Novokhatny
Original Assignee
Grifols Worldwide Operations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Worldwide Operations Ltd filed Critical Grifols Worldwide Operations Ltd
Publication of AR124640A1 publication Critical patent/AR124640A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

En la presente memoria descriptiva se dan a conocer procedimientos y composiciones para el tratamiento de heridas y úlceras en pacientes, en particular aquellos pacientes que padecen heridas y úlceras crónicas que no cicatrizan. Las fibrinogenasas, tales como la plasmina, muestran utilidad para disminuir la viscosidad plasmática o de la sangre, lo que da como resultado una mejor cicatrización de heridas y úlceras en los pacientes. Reivindicación 1: Procedimiento para el tratamiento de una herida o úlcera en un paciente que lo necesita, comprendiendo el procedimiento la administración parenteral de una cantidad eficaz terapéuticamente de una fibrinogenasa al paciente. Reivindicación 32: Procedimiento para reducir la viscosidad de la sangre en un paciente que lo necesita, comprendiendo el procedimiento la administración parenteral de una cantidad terapéuticamente eficaz de una fibrinogenasa al paciente.
ARP210103231A 2020-11-25 2021-11-23 Cicatrización de heridas AR124640A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063118473P 2020-11-25 2020-11-25

Publications (1)

Publication Number Publication Date
AR124640A1 true AR124640A1 (es) 2023-04-19

Family

ID=78819540

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210103231A AR124640A1 (es) 2020-11-25 2021-11-23 Cicatrización de heridas

Country Status (6)

Country Link
EP (1) EP4251195A1 (es)
JP (1) JP2023550301A (es)
AR (1) AR124640A1 (es)
AU (1) AU2021387774A1 (es)
CA (1) CA3196851A1 (es)
WO (1) WO2022112251A1 (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774087A (en) 1987-08-14 1988-09-27 Northwestern University Micro-size fibrinolytic plasmin
US6969515B2 (en) * 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
US7202066B2 (en) * 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
DE10390418D2 (de) * 2002-02-06 2005-01-13 N Zyme Biotec Gmbh Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
MXPA06012236A (es) 2004-04-22 2007-01-31 Talecris Biotherapeutics Inc Plasmina modificada en forma recombinante.
WO2009093970A1 (en) * 2008-01-22 2009-07-30 Omnio Healer Ab Method of improving wound healing

Also Published As

Publication number Publication date
CA3196851A1 (en) 2022-06-02
EP4251195A1 (en) 2023-10-04
AU2021387774A1 (en) 2023-06-08
WO2022112251A1 (en) 2022-06-02
JP2023550301A (ja) 2023-12-01

Similar Documents

Publication Publication Date Title
Smith Drug treatment of varicose veins, venous edema, and ulcers
Ueno et al. Evaluation of hyperbaric oxygen therapy for chronic wounds
RU2013150536A (ru) Способ и топическая композиция для обработки ран, содержащая seaprose и его применение
NI201600084A (es) Piperidinil tetrahidroquinolinas sustituidas y su uso como antagonistas de los adenoreceptores alpha-2c.
CL2020002509A1 (es) Entrega topica y transdermica de un quelante de hierro para prevenir y tratar heridas cronicas.
CR20160277A (es) Piperidinil tetrahidroquinolinas sustituidas
WO2019040185A1 (en) SARRASIN HONEY AND HEALING WELDING FOR IODIZED POVIDONE WOUND
Avijgan Phytotherapy: an alternative treatment for non-healing ulcers
ATE283835T1 (de) Salze von asiatsäure und madecasssäure geeignet für die herstellung von pharmazeutischen und kosmetischen zusammensetzungen
Gayratovna WAYS OF OPTIMIZATION OF LOCAL THERAPY FOR PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFAQIAL REGION
AR124640A1 (es) Cicatrización de heridas
AU2012307406B2 (en) Compositions for the treatment of peripheral ulcers of various origins
US20180236009A1 (en) Buckwheat honey and bacitracin wound-healing dressing
Marston Venous ulcers
US11213564B2 (en) Buckwheat honey and bacitracin wound-healing dressing
SE0401943D0 (sv) New use
Marinova TREATMENT OF COMPLICATED DEEP SOFT TISSUE INFECTIONS BY A COMBINATION OF NEGATIVE PRESSURE WOUND THERAPY AND INTRALESIONAL TOPICAL APPLICATION WITH STABLE OZONIDES OZOILE® FIRST CASES IN BULGARIA
Imran et al. Efficacy of negative pressure wound therapy using suction drain in the management of chronic wounds
Marinova THE EFFECT OF TOPICAL APPLICATION WITH OZOILE® AS A NOVEL METHOD IN THE COMPLEX TREATMENT OF SOFT TISSUE INFECTIONS AND CHRONIC WOUNDS.
RU2754383C1 (ru) Способ лечения неинфицированного послеоперационного раневого дефекта стопы при отсутствии признаков критической ишемии конечности у больных с нейропатической и нейроишемической формой синдрома диабетической стопы
RU2546030C1 (ru) Средство "ихтиосин"
UA102772U (uk) Спосіб місцевого лікування гнійних ран м'яких тканин у хворих з полівалентною алергією до антибіотиків
Saraswathy et al. Patterned wound healing effect of topical recombinant human epidermal growth factor in trophic ulcers secondary to leprosy
Allen et al. Pulsating Waves, PEMF Saves
Paolino et al. Successful Management of a Chronic Refractory Leg Ulcer in an Adolescent with Sickle Cell Anemia

Legal Events

Date Code Title Description
FB Suspension of granting procedure